November 07, 2020
4 min watch
Save
VIDEO: Brimochol shows increased visual acuity in clinical data
Issue: December 25, 2020
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this Healio Video Perspective from the virtual Eyecelerator conference, Ben Bergo, president and CEO, Visus Therapeutics, outlines the mechanism and clinical data of Brimochol, the company’s lead presbyopia-correcting eye drop candidate.